Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is 11.12% vs 5.23% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is 62.71% vs -3.11% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "252.80",
          "val2": "227.50",
          "chgp": "11.12%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "94.20",
          "val2": "89.30",
          "chgp": "5.49%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.20",
          "val2": "0.20",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "1.70",
          "val2": "0.40",
          "chgp": "325.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "116.50",
          "val2": "71.60",
          "chgp": "62.71%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "372.70%",
          "val2": "333.20%",
          "chgp": "3.95%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 14.80% vs 9.11% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 20.97% vs 2.98% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,058.80",
          "val2": "922.30",
          "chgp": "14.80%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "455.90",
          "val2": "368.50",
          "chgp": "23.72%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.10",
          "val2": "1.30",
          "chgp": "-15.38%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "3.10",
          "val2": "1.00",
          "chgp": "210.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "368.10",
          "val2": "304.30",
          "chgp": "20.97%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "376.30%",
          "val2": "342.00%",
          "chgp": "3.43%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY

Mar'26

Mar'25

Change(%)

Net Sales

252.80

227.50

11.12%

Operating Profit (PBDIT) excl Other Income

94.20

89.30

5.49%

Interest

0.20

0.20

Exceptional Items

1.70

0.40

325.00%

Consolidate Net Profit

116.50

71.60

62.71%

Operating Profit Margin (Excl OI)

372.70%

333.20%

3.95%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Mar 2026 is 11.12% vs 5.23% in Mar 2025

Consolidated Net Profit

YoY Growth in quarter ended Mar 2026 is 62.71% vs -3.11% in Mar 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

1,058.80

922.30

14.80%

Operating Profit (PBDIT) excl Other Income

455.90

368.50

23.72%

Interest

1.10

1.30

-15.38%

Exceptional Items

3.10

1.00

210.00%

Consolidate Net Profit

368.10

304.30

20.97%

Operating Profit Margin (Excl OI)

376.30%

342.00%

3.43%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is 14.80% vs 9.11% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 20.97% vs 2.98% in Dec 2024

All Annual Results